{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:52:39Z","timestamp":1759009959843},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T00:00:00Z","timestamp":1346716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1756-0500-5-484","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T09:50:20Z","timestamp":1346752220000},"source":"Crossref","is-referenced-by-count":11,"title":["A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation"],"prefix":"10.1186","volume":"5","author":[{"given":"Tatyana V","family":"Turti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N","family":"Baibarina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena A","family":"Degtiareva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena S","family":"Keshishyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurii V","family":"Lobzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla S","family":"Namazova-\u0412aranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey P","family":"Prodeus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin M","family":"Gudkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna I","family":"Kruglova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard F","family":"Notario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,4]]},"reference":[{"issue":"9725","key":"1894_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","volume":"375","author":"H Nair","year":"2010","unstructured":"Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O\u2019Brien KL, Roca A, Wright PF, Bruce N, et al: Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010, 375 (9725): 1545-1555. 10.1016\/S0140-6736(10)60206-1.","journal-title":"Lancet"},{"key":"1894_CR2","first-page":"221","volume":"2","author":"V Tatochenko","year":"2010","unstructured":"Tatochenko V, Uchaikin V, Gorelov A, Gudkov K, Campbell A, Schulz G, Prahl R, Notario G: Epidemiology of respiratory syncytial virus in children <\/=2\u2009years of age hospitalized with lower respiratory tract infections in the Russian Federation: a prospective, multicenter study. Clin Epidemiol. 2010, 2: 221-227.","journal-title":"Clin Epidemiol"},{"issue":"3","key":"1894_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/fmb.09.1","volume":"4","author":"CM Oshansky","year":"2009","unstructured":"Oshansky CM, Zhang W, Moore E, Tripp RA: The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol. 2009, 4 (3): 279-297. 10.2217\/fmb.09.1.","journal-title":"Future Microbiol"},{"issue":"4","key":"1894_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/cc6917","volume":"12","author":"N Stollenwerk","year":"2008","unstructured":"Stollenwerk N, Harper RW, Sandrock CE: Bench-to-bedside review: rare and common viral infections in the intensive care unit\u2013linking pathophysiology to clinical presentation. Crit Care. 2008, 12 (4): 219-10.1186\/cc6917.","journal-title":"Crit Care"},{"issue":"9","key":"1894_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1086\/651603","volume":"50","author":"KM Empey","year":"2010","unstructured":"Empey KM, Peebles RS, Kolls JK: Pharmacologic advances in the treatment and prevention of respiratory syncytial virus. Clin Infect Dis. 2010, 50 (9): 1258-1267. 10.1086\/651603.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1894_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/CMR.00032-09","volume":"23","author":"JS Tregoning","year":"2010","unstructured":"Tregoning JS, Schwarze J: Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin Microbiol Rev. 2010, 23 (1): 74-98. 10.1128\/CMR.00032-09.","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"1894_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.4161\/hv.6.6.11562","volume":"6","author":"JC Blanco","year":"2010","unstructured":"Blanco JC, Boukhvalova MS, Shirey KA, Prince GA, Vogel SN: New insights for development of a safe and protective RSV vaccine. Hum Vaccin. 2010, 6 (6): 482-492. 10.4161\/hv.6.6.11562.","journal-title":"Hum Vaccin"},{"issue":"5","key":"1894_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1086\/514115","volume":"176","author":"S Johnson","year":"1997","unstructured":"Johnson S, Oliver C, Prince GA, Hemming VG, Pfarr DS, Wang SC, Dormitzer M, O\u2019Grady J, Koenig S, Tamura JK, et al: Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis. 1997, 176 (5): 1215-1224. 10.1086\/514115.","journal-title":"J Infect Dis"},{"issue":"3","key":"1894_CR9","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1542\/peds.102.3.531","volume":"102","author":"The IMpact-RSV Study Group","year":"1998","unstructured":"The IMpact-RSV Study Group: Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998, 102 (3): 531-537.","journal-title":"Pediatrics"},{"issue":"4","key":"1894_CR10","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","volume":"143","author":"TF Feltes","year":"2003","unstructured":"Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH, Connor EM, Sondheimer HM: Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003, 143 (4): 532-540. 10.1067\/S0022-3476(03)00454-2.","journal-title":"J Pediatr"},{"issue":"3","key":"1894_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ppul.20503","volume":"42","author":"M Grimaldi","year":"2007","unstructured":"Grimaldi M, Gouyon B, Sagot P, Quantin C, Huet F, Gouyon JB: Palivizumab efficacy in preterm infants with gestational age\u2009<\u2009or\u2009=\u200930\u2009weeks without bronchopulmonary dysplasia. Pediatr Pulmonol. 2007, 42 (3): 189-192. 10.1002\/ppul.20503.","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"1894_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/01.inf.0000086403.50417.7c","volume":"22","author":"C Pedraz","year":"2003","unstructured":"Pedraz C, Carbonell-Estrany X, Figueras-Aloy J, Quero J: Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants. Pediatr Infect Dis J. 2003, 22 (9): 823-827. 10.1097\/01.inf.0000086403.50417.7c.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"1894_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/INF.0b013e31821146f7","volume":"30","author":"I Mitchell","year":"2011","unstructured":"Mitchell I, Paes BA, Li A, Lanctot KL: CARESS: The Canadian Registry of Palivizumab. Pediatr Infect Dis J. 2011, 30 (8): 651-655. 10.1097\/INF.0b013e31821146f7.","journal-title":"Pediatr Infect Dis J"},{"issue":"2 Suppl","key":"1894_CR14","first-page":"S46","volume":"22","author":"JR Romero","year":"2003","unstructured":"Romero JR: Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage. Pediatr Infect Dis J. 2003, 22 (2 Suppl): S46-S54.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1894_CR15","first-page":"540","volume":"22","author":"R Singleton","year":"2003","unstructured":"Singleton R, Dooley L, Bruden D, Raelson S, Butler JC: Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J. 2003, 22 (6): 540-545.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1894_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.inf.0000105106.93562.d3","volume":"23","author":"E Henckel","year":"2004","unstructured":"Henckel E, Luthander J, Berggren E, Kapadia H, Naver L, Norman M, Bennet R, Eriksson M: Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002. Pediatr Infect Dis J. 2004, 23 (1): 27-31. 10.1097\/01.inf.0000105106.93562.d3.","journal-title":"Pediatr Infect Dis J"},{"key":"1894_CR17","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2334-9-106","volume":"9","author":"SK Morris","year":"2009","unstructured":"Morris SK, Dzolganovski B, Beyene J, Sung L: A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis. 2009, 9: 106-10.1186\/1471-2334-9-106.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1894_CR18","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1542\/peds.2009-2345","volume":"124","author":"From the American Academy of Pediatrics","year":"2009","unstructured":"From the American Academy of Pediatrics: Policy statements\u2013modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections. Pediatrics. 2009, 124 (6): 1694-1701.","journal-title":"Pediatrics"},{"issue":"6","key":"1894_CR19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/INF.0b013e3182184ae7","volume":"30","author":"GF Langley","year":"2011","unstructured":"Langley GF, Anderson LJ: Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J. 2011, 30 (6): 510-517.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"1894_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/01.inf.0000137568.71589.bd","volume":"23","author":"BJ Law","year":"2004","unstructured":"Law BJ, Langley JM, Allen U, Paes B, Lee DS, Mitchell I, Sampalis J, Walti H, Robinson J, O\u2019Brien K, et al: The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004, 23 (9): 806-814. 10.1097\/01.inf.0000137568.71589.bd.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1894_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ije\/28.1.157","volume":"28","author":"MW Weber","year":"1999","unstructured":"Weber MW, Milligan P, Hilton S, Lahai G, Whittle H, Mulholland EK, Greenwood BM: Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the western region of The Gambia. Int J Epidemiol. 1999, 28 (1): 157-162. 10.1093\/ije\/28.1.157.","journal-title":"Int J Epidemiol"},{"key":"1894_CR22","unstructured":"Shafey O, Eriksen M, Ross H, Mackay J: The Tobacco Atlas. American Cancer Society, Available at: \n                    www.tobaccoatlas.org\n                    \n                  . Accessed May 12, 2011, 3"},{"key":"1894_CR23","volume-title":"Global infectious disease threat and its implications for the United States","author":"JC Gannon","year":"2000","unstructured":"Gannon JC: Global infectious disease threat and its implications for the United States. 2000, National Intelligence Council, Washington, DC"},{"key":"1894_CR24","unstructured":"WHO Health Status Statistics: Mortality. Available at: \n                    http:\/\/www.who.int\/healthinfo\/statistics\/indneonatalmortality\/en\/\n                    \n                   Accessed May 12, 2011"},{"issue":"5 Pt 1","key":"1894_CR25","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1542\/peds.111.5.e596","volume":"111","author":"T Wuhib","year":"2003","unstructured":"Wuhib T, McCarthy BJ, Chorba TL, Sinitsina TA, Ivasiv IV, McNabb SJ: Underestimation of infant mortality rates in one republic of the former Soviet Union. Pediatrics. 2003, 111 (5 Pt 1): e596-e600.","journal-title":"Pediatrics"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1756-0500-5-484\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-5-484.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:00:18Z","timestamp":1548108018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-5-484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1894"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-5-484","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,4]]},"article-number":"484"}}